Literature DB >> 32179924

Age and diabetes mellitus associated with worse outcomes after percutaneous coronary intervention in a multi-ethnic Asian dialysis patient population.

Jiang Ming Fam1, Chun Yuan Khoo1, Yee How Lau1, Weng Kit Lye2, Xinzhe James Cai1, Lina Hui Lin Choong3, John Carson Allen2, Khung Keong Yeo1.   

Abstract

INTRODUCTION: There is limited literature on clinical outcomes following percutaneous coronary intervention (PCI) in Asian dialysis patients. We evaluated the angiographic characteristics and clinical outcomes of dialysis patients treated with PCI in an Asian society.
METHODS: A retrospective analysis was performed of 274 dialysis patients who underwent PCI in a tertiary care institution from January 2007 to December 2012. Data on clinical and angiographic characteristics was collected. The primary endpoint was major adverse cardiac events (MACE), defined as a composite of cardiac death, acute myocardial infarction (AMI) and stroke at two years.
RESULTS: 274 patients (65.0% male, median age 62.0 years) with 336 lesions (81.8% Type B2) were treated. 431 stents (35.0% drug-eluting stents) with a mean diameter of 2.96 mm and mean length of 21.30 mm were implanted. The MACE rate was 55.8% (n = 153) at two years, from death (36.5%) and AMI (35.0%). In multivariable analysis, age and diabetes mellitus were significant predictors of both mortality (odds ratio [OR] 1.09, 95% confidence interval [CI] 1.05-1.12, p < 0.001; OR 2.65, 95% CI 1.46-4.82, p = 0.001, respectively) and MACE (OR 1.06, 95% CI 1.03-1.08, p < 0.001; OR 1.84, 95% CI 1.07-3.15, p = 0.027, respectively). Left ventricular ejection fraction (LVEF) (OR 0.97, 95% CI 0.95-0.99, p = 0.006) was a significant predictor of mortality but not MACE.
CONCLUSION: Asian dialysis patients who underwent PCI had a two-year MACE rate of 55.8% due to death and AMI. Age, LVEF and diabetes mellitus were significant predictors of mortality at two years. Copyright: © Singapore Medical Association.

Entities:  

Keywords:  coronary artery disease; percutaneous coronary intervention; renal dialysis

Mesh:

Year:  2020        PMID: 32179924      PMCID: PMC8801832          DOI: 10.11622/smedj.2020025

Source DB:  PubMed          Journal:  Singapore Med J        ISSN: 0037-5675            Impact factor:   1.858


  27 in total

1.  Accelerated atherosclerosis in prolonged maintenance hemodialysis.

Authors:  A Lindner; B Charra; D J Sherrard; B H Scribner
Journal:  N Engl J Med       Date:  1974-03-28       Impact factor: 91.245

2.  Onset of coronary artery disease prior to initiation of haemodialysis in patients with end-stage renal disease.

Authors:  N Joki; H Hase; R Nakamura; T Yamaguchi
Journal:  Nephrol Dial Transplant       Date:  1997-04       Impact factor: 5.992

3.  Endothelial dysfunction in chronic renal failure: roles of lipoprotein oxidation and pro-inflammatory cytokines.

Authors:  C H Bolton; L G Downs; J G Victory; J F Dwight; C R Tomson; M I Mackness; J H Pinkney
Journal:  Nephrol Dial Transplant       Date:  2001-06       Impact factor: 5.992

4.  Are patients with renal failure good candidates for percutaneous coronary revascularization in the new device era?

Authors:  M H Rubenstein; L C Harrell; B V Sheynberg; H Schunkert; H Bazari; I F Palacios
Journal:  Circulation       Date:  2000-12-12       Impact factor: 29.690

5.  Cardiovascular disease after renal transplantation.

Authors:  B L Kasiske; C Guijarro; Z A Massy; M R Wiederkehr; J Z Ma
Journal:  J Am Soc Nephrol       Date:  1996-01       Impact factor: 10.121

6.  Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization.

Authors:  Alan S Go; Glenn M Chertow; Dongjie Fan; Charles E McCulloch; Chi-yuan Hsu
Journal:  N Engl J Med       Date:  2004-09-23       Impact factor: 91.245

7.  25-hydroxyvitamin D and risk of myocardial infarction in men: a prospective study.

Authors:  Edward Giovannucci; Yan Liu; Bruce W Hollis; Eric B Rimm
Journal:  Arch Intern Med       Date:  2008-06-09

8.  A comparison of coronary angioplasty and coronary artery bypass grafting outcomes in chronic dialysis patients.

Authors:  A L Rinehart; C A Herzog; A J Collins; J M Flack; J Z Ma; J A Opsahl
Journal:  Am J Kidney Dis       Date:  1995-02       Impact factor: 8.860

Review 9.  Percutaneous coronary intervention in chronic kidney disease patients.

Authors:  George M Tadros; Charles A Herzog
Journal:  J Nephrol       Date:  2004 May-Jun       Impact factor: 3.902

10.  Outcome in patients on continuous ambulatory peritoneal dialysis and haemodialysis: 4-year analysis of a prospective multicentre study.

Authors:  R Gokal; C Jakubowski; J King; L Hunt; S Bogle; R Baillod; F Marsh; C Ogg; D Oliver; M Ward
Journal:  Lancet       Date:  1987-11-14       Impact factor: 79.321

View more
  2 in total

1.  Prognostic value of peripheral blood circular RNAs in patients with acute coronary syndrome.

Authors:  Chen Chen; Xiwen Zhao; Xiaoliang Xie
Journal:  J Thorac Dis       Date:  2022-04       Impact factor: 2.895

2.  Serum VCAM-1 and ICAM-1 measurement assists for MACE risk estimation in ST-segment elevation myocardial infarction patients.

Authors:  Jiancai Yu; Yongxing Liu; Wanzhong Peng; Zesheng Xu
Journal:  J Clin Lab Anal       Date:  2022-08-31       Impact factor: 3.124

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.